#USA #New York #Class Action #Bronstein Gewirtz #Dentsply Sirona

Overview of the Class Action Lawsuit Against Dentsply Sirona

Bronstein, Gewirtz & Grossman LLC, a prominent law firm, has initiated a class action lawsuit against Dentsply Sirona Inc. (NASDAQ: XRAY) and several of its officers. This litigation targets investors who experienced significant losses while acquiring Dentsply securities between December 1, 2022, and November 6, 2024. If you are among those affected, this is an opportunity to join the lawsuit and potentially recover damages.

Allegations Against Dentsply Sirona

The complaint articulates several serious allegations against Dentsply and its management:

1. Misleading Practices: Dentsply allegedly targeted vulnerable populations, particularly low-income individuals lacking proper oral hygiene education and access to dental care or insurance. Many of these patients, who signed up for their Byte aligners, had underlying dental issues, making them ineligible for necessary treatments.

2. Aggressive Sales Tactics: The lawsuit suggests that the company's sales pressures influenced employees to sell aligners to patients who were not suitable candidates for such treatments.

3. Inadequate Patient Safety Protocols: It is alleged that Dentsply's onboarding process for Byte did not ensure that patient safety was prioritized, thereby compromising the quality of care.

4. Failure to Report Injuries: Despite an influx of injury reports from Byte patients, Dentsply is accused of neglecting its duty to investigate these claims and to report them to the FDA, which is required within a specific timeframe under federal regulations.

5. Inflating Goodwill Value: Due to the aforementioned issues, it is claimed that Dentsply significantly overstated the goodwill valuation of its Byte product.

6. False Public Statements: Throughout the class period, the company's executives reportedly made misleading statements regarding the business's health, operations, and long-term outlook.

Next Steps for Affected Investors

Those who have suffered losses are encouraged to take action. Bronstein, Gewirtz & Grossman LLC is inviting potential plaintiffs to review the Complaint, which can be accessed at their website, bgandg.com/XRAY. If you want to be appointed as the lead plaintiff, the deadline is January 27, 2025. However, it is important to note that you do not need to serve as lead plaintiff to participate in any financial recovery.

No Upfront Costs Involved

It's worth noting that the law firm operates on a contingency basis. This means that fees for legal representation are only owed if the case is won or settles successfully, allowing for broader access to legal recourse for investors.

About Bronstein, Gewirtz & Grossman LLC

With a strong reputation in the legal field, Bronstein, Gewirtz & Grossman LLC specializes in representing investors impacted by securities fraud. The firm has successfully reclaimed hundreds of millions for investors in similar situations across the nation, showcasing their commitment to protect investors' rights.

For those interested in learning more or determining their eligibility to participate, they can reach out to Peretz Bronstein or Nathan Miller at 332-239-2660 for further assistance.

Conclusion

The filing of this class action represents a significant legal step for investors who have faced challenges due to Dentsply's actions. The outcome of this case could not only lead to potential financial recoveries but also encourage greater accountability in the corporate practices of healthcare companies like Dentsply Sirona, ultimately promoting better patient safety and ethics in the industry.